Trials / Conditions / Anaplastic Ependymoma

Anaplastic Ependymoma

15 registered clinical trials studyying Anaplastic Ependymoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors NCT05278208	Nationwide Children's Hospital	Phase 1 / Phase 2
Active Not Recruiting	A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma an NCT04978727	Children's Oncology Group	Phase 1
Withdrawn	Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer NCT04521946	M.D. Anderson Cancer Center	Phase 1
Terminated	Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma NCT03727841	National Cancer Institute (NCI)	Phase 2
Recruiting	LET Optimized IMPT in Treating Pediatric Patients With Ependymoma NCT03750513	M.D. Anderson Cancer Center	Phase 1
Completed	SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies fo NCT03434262	St. Jude Children's Research Hospital	Phase 1
Completed	Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma NCT02101905	National Cancer Institute (NCI)	Phase 1
Terminated	Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine NCT02722512	Ann & Robert H Lurie Children's Hospital of Chicago	Phase 1
Terminated	Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors NCT01836549	Pediatric Brain Tumor Consortium	Phase 2
Terminated	Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas NCT01721577	Rush University Medical Center	Phase 1 / Phase 2
Completed	Carboplatin and Bevacizumab for Recurrent Ependymoma NCT01295944	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Pat NCT01096368	Children's Oncology Group	Phase 3
Completed	Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions NCT01082926	City of Hope Medical Center	Phase 1
Terminated	Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma NCT01095094	Case Comprehensive Cancer Center	Phase 2
Withdrawn	Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors NCT00243490	National Taiwan University Hospital	Phase 2